Results 71 to 80 of about 233,217 (309)
Allosensitization and outcomes in pediatric heart transplantation
Allosensitization among children being considered for heart transplantation remains a great challenge. Controversy exists as to the best approach for those with elevated panel-reactive antibody (PRA) titers.
Rusconi, Paolo +13 more
core +1 more source
All‐Polyimide‐Mediated Liquid Metal Assembly on Aerogels for Breathable and Robust Electronic Skins
An all‐polyimide‐mediated assembly strategy resolves the fundamental conflict between physiological breathability and electromechanical robustness in wearable electronics. By integrating a polyamic acid‐encapsulated liquid metal ink onto an ultralight polyimide aerogel, imidization‐induced contraction enables low‐temperature conductive activation and ...
Haijun Zhu +18 more
wiley +1 more source
Background and aims: Vericiguat lowers cardiovascular death or heart-failure hospitalization in recently worsened heart failure with reduced ejection fraction (HFrEF), but its effects on cardiac remodeling are less well characterized.
Tine Bajec +10 more
doaj +1 more source
Heart transplantation: its risks, the expectations, and cultural negotiations in Japan
PhDThe aim of this thesis is to facilitate an understanding of the experiences of Japanese heart transplant recipients in terms of how their identities are transformed.
Tomomatsu, Ikuko
core
Transplant arteriosclerosis : an experimental study on risk factors and pathogenetic mechanisms [PDF]
In this thesis, we focused on vascular damage inflicted after transplantation, i.e. injury of the graft vasculature as a result of an alloreactive response of the host against the graft, and everal factors in-fluencing this process.
Hillebrands, Jan Lucas +2 more
core
Our study identifies the HDACs‐STAT3 axis as key regulator for M2 macrophage accumulation in DLBCL. We developed Chid@M2pep‐EVs/TP, a pH‐responsive drug delivery system for M2 macrophage specific chidamide administration. By coupling M2‐targeted chidamide with EVs‐mediated delivery, this system reprograms M2 to M1 via HDAC inhibition and STAT3 ...
Bo Dai +15 more
wiley +1 more source
Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure
Aim of the Review. The aim of this review is to discuss recent advances in clinical aspects of stem cell therapy in chronic nonischemic heart failure (DCMP) with emphasis on patient selection, stem cell types, and delivery methods.
Gregor Poglajen +6 more
doaj +1 more source
Recurrent left-sided heart leiomyosarcoma: should heart transplantation be legitimate?
Leiomyosarcoma of the heart is an uncommon primary malignant tumor with poor postoperative survival that may be measured in months. A leiomyosarcoma of the left atrium was diagnosed in a 47-year-old man.
Massetti, Massimo
core
Cannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes
Heart transplantation (HT) remains the optimal therapy for many patients with advanced heart failure. Use of substances of potential abuse has historically been a contraindication to HT.
Ilonze, Onyedika J. +6 more
core +1 more source
This study explores the use of N, S co‐doped carbon quantum dots (NS‐CQDs) as carriers for riboflavin, creating NS‐CQDs‐RF composite photosensitizers. These composites improve riboflavin absorption, enhance ROS generation efficiency, and preserve corneal epithelium integrity.
Tinghong Xu +9 more
wiley +1 more source

